Chemoinformaics analysis of 5,5,9-TRIMETHYL-14-METHYLIDENETETRACYCLO[11.2.1.01,10.04,9]HEXADECANE
| Molecular Weight | 272.476 | nRot | 0 |
| Heavy Atom Molecular Weight | 240.22 | nRig | 17 |
| Exact Molecular Weight | 272.25 | nRing | 4 |
| Solubility: LogS | -3.274 | nHRing | 0 |
| Solubility: LogP | 1.079 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 54.7374 |
| nHD | 0 | BPOL | 32.1026 |
| QED | 0.514 |
| Synth | 3.461 |
| Natural Product Likeliness | 2.109 |
| NR-PPAR-gamma | 0.741 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.006 |
| HIA | 0.186 |
| CACO-2 | -5.635 |
| MDCK | 0.00000498 |
| BBB | 0.024 |
| PPB | 0.867899 |
| VDSS | 0.588 |
| FU | 0.105117 |
| CYP1A2-inh | 0.253 |
| CYP1A2-sub | 0.351 |
| CYP2c19-inh | 0.094 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.526 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.224 |
| CYP2d6-sub | 0.48 |
| CYP3a4-inh | 0.181 |
| CYP3a4-sub | 0.264 |
| CL | 17.691 |
| T12 | 0.84 |
| hERG | 0.048 |
| Ames | 0.592 |
| ROA | 0.459 |
| SkinSen | 0.956 |
| Carcinogencity | 0.088 |
| EI | 0.915 |
| Respiratory | 0.206 |
| NR-Aromatase | 0.645 |
| Antiviral | No |
| Prediction | 0.653218 |